-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Initiates Coverage On Centessa Pharmaceuticals with Overweight Rating, Announces Price Target of $38

Benzinga·03/31/2025 10:05:53
Listen to the news
Piper Sandler analyst Biren Amin initiates coverage on Centessa Pharmaceuticals (NASDAQ:CNTA) with a Overweight rating and announces Price Target of $38.